东方生物: 第三届监事会第十三次会议决议公告

Core Points - The Supervisory Board of Zhejiang Oriental Gene Biological Products Co., Ltd. confirmed that the procedures for preparing and reviewing the 2025 semi-annual report comply with legal and regulatory requirements, and the report accurately reflects the company's actual situation without any false records or significant omissions [1][2] - The Supervisory Board has decided to abolish the Supervisory Board and its functions will be transferred to the Audit Committee of the Board of Directors, with relevant internal regulations being revised accordingly [2][3] - The proposal to cancel the Supervisory Board requires approval from the shareholders' meeting before implementation [2]